Sofosbuvir and simeprevir for treatment of hepatitis C virus infection in liver transplant recipients. (Q41137675)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825070%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

Sofosbuvir and simeprevir for treatment of hepatitis C virus infection in liver transplant recipients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825070%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

0 references

1 reference

1 reference

Julio A Gutierrez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825070%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Andres F Carrion

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825070%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Danny Avalos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825070%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Christopher O'Brien

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825070%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Paul Martin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825070%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Kalyan Ram Bhamidimarri

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825070%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Adam Peyton

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825070%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

publication date

1 June 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825070%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

published in

Liver Transplantation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825070%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825070%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825070%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

823-830

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825070%20AND%20SRC:MED&resulttype=core&format=json

Diagnosis, management, and treatment of hepatitis C: an update

4 March 2020

cites work

1 reference

The impact of disease recurrence on graft survival following liver transplantation: a single centre experience

21 January 2018

1 reference

Progression of liver fibrosis in post-transplant hepatitis C: mechanisms, assessment and treatment

21 January 2018

1 reference

The natural history of hepatitis C cirrhosis after liver transplantation

21 January 2018

1 reference

The association between hepatitis C infection and survival after orthotopic liver transplantation

21 January 2018

1 reference

Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study.

21 January 2018

1 reference

Antiviral therapy and fibrosis progression in patients with mild-moderate hepatitis C recurrence after liver transplantation. A randomized controlled study.

21 January 2018

1 reference

Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin

21 January 2018

1 reference

Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experience

21 January 2018

1 reference

Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation

21 January 2018

1 reference

Sofosbuvir for previously untreated chronic hepatitis C infection

21 January 2018

1 reference

Sofosbuvir and ribavirin in HCV genotypes 2 and 3.

21 January 2018

1 reference

Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial

21 January 2018

1 reference

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial

21 January 2018

1 reference

Simeprevir with peginterferon and ribavirin leads to high rates of SVR in patients with HCV genotype 1 who relapsed after previous therapy: a phase 3 trial

21 January 2018

1 reference

Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation

21 January 2018

1 reference

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study

21 January 2018

1 reference

Management of hepatitis C infection after liver transplantation

21 January 2018

1 reference

The natural history of recurrent hepatitis C and what influences this

21 January 2018

1 reference

Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation

21 January 2018

1 reference

Recurrent HCV after liver transplantation-mechanisms, assessment and therapy

21 January 2018

1 reference

Fibrosis progression in hepatitis C positive liver recipients after sustained virologic response to antiviral combination therapy (interferon-ribavirin therapy).

21 January 2018

1 reference

Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.

21 January 2018

1 reference

Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C.

21 January 2018

1 reference

Drug-drug interactions during antiviral therapy for chronic hepatitis C

21 January 2018

1 reference

An interferon-free antiviral regimen for HCV after liver transplantation

21 January 2018

1 reference

Protease inhibitor-based triple therapy is highly effective for hepatitis C recurrence after liver transplant: a multicenter experience

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25825070

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Sustained virological response to antiviral therapy improves survival rate in patients with recurrent hepatitis C virus infection after liver transplantation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25825070

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25825070

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/LT.24126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825070%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825070%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

PubMed publication ID

25825070

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825070%20AND%20SRC:MED&resulttype=core&format=json